FVN
NASDAQ · N/A
Future Vision Ii Acquisition
$11.80
+0.51 (+4.52%)
Open$10.71
Previous Close$11.29
Day High$12.18
Day Low$10.60
52W High$17.00
52W Low$7.90
Volume—
Avg Volume116.6K
Market Cap88.87M
P/E Ratio43.67
EPS$0.27
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 61.07M | 57.04M | 61.55M |
| Net Income | 4.07M | 4.36M | 5.05M |
| Profit Margin | 6.7% | 7.7% | 8.2% |
| EBITDA | 7.06M | 7.39M | 8.24M |
| Free Cash Flow | 4.49M | 4.39M | 5.27M |
| Rev Growth | +2.4% | -8.2% | +9.8% |
| Debt/Equity | 0.85 | 0.72 | 0.83 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $3.03 | +34.07% | — | 1.41B |
| PICS | Pics Nv | $11.49 | +0.70% | 6.6 | 1.48B |
| DMII | Drugs Made In America Acquis | $10.13 | +0.10% | 75.2 | 645.28M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.75 | +0.55% | 35.5 | 336.67M |
| CEPF | Cantor Equity Partners-Cl A | $10.39 | +0.14% | 57.9 | 595.50M |